Peritoneal dialysis-associated peritonitis with simultaneous exit-site infection

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 126-130

  Mehrotra, Rajnish ^a   Singh, Harmanjit ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; GENTAMICIN; ICODEXTRIN; PSEUDOMONIC ACID; VANCOMYCIN;

ABDOMINAL PAIN; ANTIMICROBIAL THERAPY; ARTICLE; ERYTHEMA; FOLLOW UP; GRAM STAINING; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PERITONITIS; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DEVICE REMOVAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84872178727     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06910712     Document Type: Article

References (28)

1. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG; International Society for Peritoneal Dialysis: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30: 393-423, 2010
2. Rocklin MA, Teitelbaum I: Noninfectious causes of cloudy peritoneal dialysate. Semin Dial 14: 37-40, 2001
3. Boer WH, Vos PF, Fieren MW: Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis. Perit Dial Int 23: 33-38, 2003
4. Touré F, Lavaud S, Mohajer M, Lavaud F, Canivet E, Nguyen P, Chanard J, Rieu P: Icodextrin-induced peritonitis: Study of five cases and comparison with bacterial peritonitis. Kidney Int 65: 654-660, 2004
5. Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier MA, Mendoza O, Goud N, Costigan A, Denjoy N, Verger C, Owen WF Jr: Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 365: 588-594, 2005
6. Rozenberg R, Magen E, Weissgarten J, Korzets Z: Icodextrin-induced sterile peritonitis: The Israeli experience. Perit Dial Int 26: 402-405, 2006
7. Cheung CK, Khwaja A: Chylous ascites: An unusual complication of peritoneal dialysis. A case report and literature review. Perit Dial Int 28: 229-231, 2008
8. Gonthier D, Bernardini J, Holley JL, Piraino B: Erythema: Does it indicate infection in a peritoneal catheter exit site? Adv Perit Dial 8: 230-233, 1992
9. Gupta B, Bernardini J, Piraino B: Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 28: 415-419, 1996
10. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16: 539-545, 2005
11. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 27: 695-700, 1996
12. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31: 614-630, 2011
13. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA: Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 13: 1870-1871, 1998
14. Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 7: 2403-2408, 1996
15. Mujais S: Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 103: S55-S62, 2006
16. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34: 14-20, 1999
17. Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK: Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: Effect on residual renal function. Kidney Int 68: 2375-2380, 2005
18. Wong KM, Chan YH, Cheung CY, Chak WL, Choi KS, Leung SH, Leung J, Chau KF, Tsang DN, Li CS: Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Am J Kidney Dis 38: 127-131, 2001
19. Leung CB, Szeto CC, Chow KM, Kwan BC, Wang AY, Lui SF, Li PK: Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis-a randomized controlled trial. Perit Dial Int 24: 440-446, 2004
20. Fontán MP, Cambre HD, Rodríguez-Carmona A, Muniz AL, Falcón TG: Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: Clinical outcomes and bacterial susceptibility over two decades. Perit Dial Int 29: 310-318, 2009
21. Low CL, Gopalakrishna K, Lye WC: Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 11: 1117-1121, 2000
22. Grabe DW, Bailie GR, Eisele G, Frye RF: Pharmacokinetics of intermittent intraperitoneal ceftazidime. Am J Kidney Dis 33: 111-117, 1999
23. Manley HJ, Bailie GR, Frye R, Hess LD, McGoldrick MD: Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. J Am Soc Nephrol 11: 1310-1316, 2000
24. Ruger W, van Ittersum FJ, Comazzetto LF, Hoeks SE, ter Wee PM: Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis. Perit Dial Int 31: 39-47, 2011
25. Piraino B, Bernardini J, Fried L, Johnston JR: Pain due to peritonitis. Perit Dial Int 19: 583-584, 1999
26. Mitra A, Teitelbaum I: Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines. Adv Perit Dial 19: 255-259, 2003
27. Lui SL, Yip T, Tse KC, Lam MF, Lai KN, Lo WK: Treatment of refractory pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter. Perit Dial Int 25: 560-563, 2005
28. Figueiredo A, Goh BL, Jenkins S, Johnson DW, Mactier R, Ramalakshmi S, Shrestha B, Struijk D, Wilkie M; International Society for Peritoneal Dialysis: Clinical practice guidelines for peritoneal access. Perit Dial Int 30: 424-429, 2010